Stay updated with breaking news from Authorized Generic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The most common asthma inhaler for children was discontinued at the start of this year, forcing parents and pediatricians to scramble to switch to an alternative. But more than a month later, the situation has not improved, and families remain caught in the middle of a fight between a drug company and pharmacy benefit managers…
Due to the convoluted drug pricing and reimbursement system, the authorized generic asthma med Flovent won’t be as broadly covered by PBMs as the original brand was.
A new “authorized generic” version will be available in its place, but experts worry about access.
The discontinuation aligns with a change to Medicaid rebates that may have had the inhaler’s manufacturer selling the drug at a loss.
This week, Sens. Ossoff and Warnock focused on maternal health research; uninsured patients affording insulin; specialty crop farmers; expanded health care for service members; water projects along the Chattahoochee River; and national security.